IN Brief:
- The FSA and FSS have published the first UK safety guidance covering foods and ingredients made through precision fermentation.
- The framework defines how products should be classified under existing hygiene law and what evidence regulators expect on identity, purity, allergenicity, residues and process controls.
- The move adds regulatory structure as fermentation-derived proteins, fats, vitamins and other ingredients move closer to commercial scale.
The UK’s food regulators have published the first formal safety guidance for foods and ingredients made using precision fermentation, setting out how these products should be handled under existing hygiene law and how applicants will be expected to demonstrate safety. Issued jointly by the Food Standards Agency and Food Standards Scotland, the guidance gives the sector a more detailed regulatory baseline at a point when fermentation-derived proteins, fats, vitamins and other functional ingredients are moving from pilot production towards larger commercial runs.
The framework defines precision fermentation as the use of selected or modified microorganisms, grown in controlled conditions, to produce specific target molecules with high purity. It also makes clear that the resulting ingredient must be separated from the fermentation broth and purified before use in food. From a regulatory standpoint, one of the most important clarifications concerns classification. Where animal-derived cells, tissue or material are introduced at any stage of the process, the product may fall within existing products-of-animal-origin hygiene rules for the purposes of Regulation (EC) 853/2004, bringing a different set of production and compliance requirements into play.
The guidance is less about creating a new legal category than about clarifying how existing law applies to a fast-moving technology base. The document is framed around classification and hazard analysis and critical control point principles, and it is intended to help businesses understand which hygiene requirements apply, what food business operators are responsible for, and how compliance should be evidenced in practice.
Alongside the guidance, the regulators have also laid out the technical issues that are likely to shape novel food assessments for precision fermented ingredients. Those include DNA-based identification of the production strain, checks for genetic features that could indicate hazards, evidence that manufacturing removes unwanted residues, and proportionate assessment of nutritional value and stability. Where a precision fermented protein is intended to contribute meaningfully to dietary intake, digestibility and allergenicity testing move closer to the centre of the dossier. Where an ingredient is used only at low levels for a technical function, the evidence burden may be different.
The regulators’ technical review also points to a more granular approach to process control. Whole genome sequencing is treated as the most reliable way to confirm microbial identity and identify potential warning signs, but computational screening alone is not enough. Laboratory evidence remains essential, particularly where questions arise over toxins, residual DNA, antibiotic resistance markers or the effectiveness of inactivation steps. Kill-step validation, batch-to-batch consistency and robust shelf-life studies are all highlighted as areas where supporting data needs to be strong if an application is to move efficiently through review.
A beta-lactoglobulin case study used in the regulators’ expert work illustrates the direction of travel. Rather than treating allergenicity, digestibility, composition, contaminants and nutritional implications as isolated checks, the approach draws them into a single evidence package linked to the intended use of the ingredient and the way it behaves during processing and storage. That is a more exacting model than a simple compositional comparison, but it also gives applicants a clearer picture of what a credible dossier looks like.
The guidance lands as the FSA and FSS identify precision and biomass fermentation among the food technologies most likely to generate regulatory activity over the coming decade. It also sits alongside the regulators’ precision fermentation business support service pilot, which was launched in September 2025 and runs until 31 March 2026 to help prospective applicants prepare for market authorisation. For businesses targeting Northern Ireland, the route remains different, with novel foods and related processes still following EU authorisation rules. Even so, the latest guidance gives Great Britain a firmer operating framework for one of the sector’s most technically ambitious ingredient platforms.
